review Open AccessTop 1% cited
Resveratrol: A review of preclinical studies for human cancer prevention
Toxicology and Applied Pharmacology · 2007 · Vol. 224(3) · pp. 274–283
Mohammad Athar(Columbia University)Jung Ho Back(Columbia University)Xuemei Tang(Columbia University)Kwang J. Kim(Hallym University)Levy Kopelovich(National Cancer Institute)David R. Bickers(Columbia University)A‐Young Kim✉(Columbia University)
Sirtuins and Resveratrol in MedicineBioactive natural compoundsTea Polyphenols and EffectsResveratrolCarcinogenesisPhytoalexinCancerIn vivoPharmacologyCancer researchCancer preventionBiologyMedicine
MeSH terms
ResveratrolAnimalsDrug Screening Assays, AntitumorHumansNeoplasmsStilbenesAnticarcinogenic Agents
Funding
- National Institutes of Health
Citations
718
FWCI
27.96
field-weighted impact
References
117
Percentile
100%
vs. same field & year
Citations per year
Cited by
Bioactive and nutrient composition of Camellia sinensis (Tea plant) leaves
Journal of Medicinal Plants Studies · 2022 · 2 citations
Acetyl Coenzyme A: A Central Metabolite and Second Messenger
Cell Metabolism · 2015 · 1,310 citations
Dietary Polyphenols and Their Role in Oxidative Stress-Induced Human Diseases: Insights Into Protective Effects, Antioxidant Potentials and Mechanism(s) of Action
Frontiers in Pharmacology · 2022 · 912 citations
Natural products: An evolving role in future drug discovery
European Journal of Medicinal Chemistry · 2011 · 849 citations
References
Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells
Carcinogenesis · 2001 · 415 citations
Therapeutic potential of resveratrol: the in vivo evidence
Nature Reviews Drug Discovery · 2006 · 3,859 citations
Related articles
Anti-Inflammatory Action and Mechanisms of Resveratrol
Molecules · 2021 · 633 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.